Chemours Faces Securities Class Action; Deadline Set for December 7
A securities class action lawsuit has been filed against The Chemours Company and certain senior executives in the U.S. District Court for the District of Delaware. The complaint, captioned Darcy v. The Chemours Company, alleges securities fraud and violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 following a significant decline in stock price. Investors seeking to serve as lead plaintiff must file their applications by the December 7 deadline.
Bleichmar Fonti & Auld LLP announced that a securities class action lawsuit has been filed against The Chemours Company (CC) and certain senior executives. The class action deadline is December 7.
The lawsuit alleges securities fraud following a significant stock drop and cites potential violations of federal securities laws. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Chemours securities.
The class action is pending in the U.S. District Court for the District of Delaware. The case is captioned Darcy v. The Chemours Company, No. 26-cv-1299.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles








Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.